Getting there: Presentation >> E-book of abstracts

e-book of abstracts

The e-book is available here.

The poster sessions will be divided by the following criteria:

- Cheminformatics & Bioinformatics (CAB): Monday, 10: CAB-001 till CAB-050 / Tuesday, 11: CAB-051 till CAB-092.

- Drug discovery & development (DDD): Monday, 10: DDD-001 till DDD-020 / Tuesday, 11: DDD-021 till DDD-051.

- Medicinal chemistry approaches (MCA): Monday, 10: MCA-001 till MCA012 / Tuesday, 11: MCA-013 till MCA-028.

- Synthesis and biological activity (SBA): Monday, 10: SBA-001 till SBA-050 / Tuesday, 11: SBA-051 till SBA-093.


Posters selected for oral presentation:

- Understanding miltefosine-membrane interactions using molecular dynamics simulations
Sá, M. M.(1, 2); Sresht, V.(1); Rangel-Yagui, C. O.(2); Blankschtein, D.(1) (1) Massachusetts Institute of Technology, Department of Chemical Engineering, Cambridge, MA, USA. (2) University of São Paulo, School of Pharmaceutical Sciences, Department of Pharmacy, São Paulo, SP, Brazil.

- Cation-π interactions play a key role in the binding of new CREBBP bromodomain inhibitors
Cortopassi, W. A. (1); Rooney, T.P.C. (1); Brand, M. (1); Dr. Filippakopoulos, P. (2); Dr. Brennan, P.E. (2); Prof. Dr. Conway S.J. (1); Prof. Dr. Paton, R. S (1). (1) Department of Chemistry, Chemistry Research Laboratory, University of Oxford, UK & (2) Structural Genomics Consortium, Old Road Campus Research Building, University of Oxford, UK

- Association of the anti-tuberculosis drug rifampicin with PAMAM dendrimer: a molecular dynamics simulation study.
Bellini, R. G. (1); Guimarães, A. P. (2); Dias, D. M. (1); Pacheco, M. A. C. (1); Rodrigues-Furtado, V. L. (3); de Alencastro, R. B. (3); Horta, B. A. C.(3) (1) Dpto. Eng. Elétrica, PUC-Rio, Rio de Janeiro, (2) Dpto. Química, UFV, Viçosa. (3) Instituto de Química, UFRJ, Rio de Janeiro.

- The first crystal structures of fragment-like inhibitors bound to cruzain provides new insights for novel inhibitors design
Fernandes, W. B. (1,2); McKerrow, J. H. (2); Montanari, C. A. (1) (1) Grupo de Química Medicinal do IQSC / USP (NEQUIMED), Universidade de Sao Paulo, Sao Carlos, Brazil. (2) Center for Discovery and Innovation in Parasitic Diseases (CDIPD), University of California San Francisco, USA.

- C-7 Substituted artemisinin derivatives
Gunduluru, M.(1); Illendula, A.(1); Carvalho; P.B.(1,#); Chittiboyina, A.G.(1); Muraleedharan, K.M.(1); Tekwani, B.L. (1); Williamson, J.S.(1,@); Avery, M.A.(1), (1)Department of Medicinal Chemistry, School of Pharmacy, University of Mississippi, University, MS 38677 @Current Address: National Institute of Health, Bethesda, MD 20892 # Current Address: School of Pharmacy, Notre Dame of Maryland University, Baltimore, MD 21210

- Design and Synthesis of Rac1 inhibitors as Potential Antitumor Agents
Ciarlantini, M.(1); Gonzalez, N.(2): Defelipe, L.(3), Gandolfi Donadio,L.(1); Turjanski, A.(3); Lorenzano Menna, P.(2); Comin, M. J. (1) (1) Instituto Nacional de Tecnología Industrial (2) Laboratorio de Oncología Molecular. Universidad Nacional de Quilmes. (3) Grupo de Bioinformática Estructural, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires


You can check your abstract by using our search engine. For a broad search, please, click on 'all sessions' tab and then type the information you want at the search box:

© Copyright 2014 Comitê Organizador do BrazMedChem